The study elucidates the relationship between AhR and FGF-21, providing an experimental basis for the search of new targets for the prevention and treatment of nonalcoholic fatty liver disease (NAFLD). The gene discussed is AHR; the disease is metabolic dysfunction-associated steatotic liver disease.